NCT00845637 Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period Status COMPLETED Phase PHASE1
NCT00829348 Short Message Service (SMS) Impact on Patient Compliance Receiving Long Term Lipid Lowering Therapy With Statins Status COMPLETED Phase NA
NCT00768274 Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol Status COMPLETED Phase PHASE1/PHASE2
NCT00749788 Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels Status COMPLETED Phase PHASE2
NCT00728910 Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study Status COMPLETED Phase PHASE2
NCT00726856 Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED) Status COMPLETED Phase N/A
NCT00712049 Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT) Status UNKNOWN Phase PHASE4
NCT00708370 A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients. Status COMPLETED Phase PHASE4
NCT00697203 A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C) Status COMPLETED Phase PHASE2
NCT00694239 Risk Assessment and Treat Compliance in Hypertension Education Trial Status COMPLETED Phase NA
NCT00689442 Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels Status COMPLETED Phase PHASE2
NCT00688558 Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels Status COMPLETED Phase PHASE2
NCT00684151 Survey of Lipid Goal Attainment and Mortality in Patients With High Cardiovascular Risk in Thailand Status COMPLETED Phase N/A
NCT00680017 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease Status COMPLETED Phase PHASE3
NCT00673881 ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study Status COMPLETED Phase PHASE1/PHASE2